The national medicines regulator has intensified its enforcement action against the unlawful manufacture and distribution of unregistered GLP-1 therapies. This development comes as concerns grow over South Africa’s rapidly expanding and largely unregulated weight-loss drug market. The South African Health Products Regulatory Authority (SAHPRA) and the South African Pharmacy Council (SAPC) confirmed they seized several injectable products. The raid took…